Navigation Links
Lilly Statement Regarding President Obama's Meeting With U.S. Business Leaders
Date:12/15/2010

INDIANAPOLIS, Dec. 15, 2010 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today issued the following statement from John Lechleiter, Ph.D., chairman, president, and chief executive officer about his meeting today with President Obama and other business leaders regarding economic growth, job creation, American innovation and competiveness:

"It's an honor to represent Lilly and the biopharmaceutical industry and take part in this very important dialogue today with the President and other leaders across many industries. Fostering an environment that encourages innovation is fundamental to American job growth. For instance, our industry has a long history of addressing critical medical needs through innovative research and discovery. We need policies that support and help sustain American innovation.

"We also believe that local innovation hubs – such as the life science hub we have in Indiana -- can serve as the fuel for national prosperity. From 2001 to 2007, employment in Indiana life sciences industries grew at more than twice the national rate. The annual wage of a typical life sciences job in Indiana is more than double the average wage in the state. And the total value of Indiana life sciences exports more than doubled between 2002 and 2007. I look forward to discussing how Indiana's success story can be used as a model for job growth.

"Ultimately, with public policies that provide the right environment, I'm convinced America can out-innovate anyone and create a new wave of good jobs here at home."

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Suspends Phase III Trial in Metastatic Melanoma
2. Lilly Declares First-Quarter 2011 Dividend
3. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
4. Lilly Surpasses United Way 2010 Campaign Goal
5. Breast Cancer Message Barred in Eli Lillys Hometown
6. Eli Lilly and Company to Open a Diabetes-Focused Research Center in China
7. Lilly USA, LLC Wins Award in 2010 National Health Information Awards Program
8. Lilly CEO: Are We Getting Our Moneys Worth from Medical Innovation?
9. MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint
10. Eli Lilly and Company and PPD, Inc., Honored for Building Strong Clinical Research Site Partnerships at the Site Solutions Summit Annual Meeting
11. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
(Date:1/19/2017)... 2017 While various reports ... reducing the FDA,s regulatory strictness as a way ... drug industry, many of the leading biotech and ... and development of advanced drug treatments and therapies.  ... developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it will be co-hosting ... in innovative excipients and drug delivery solutions to health industries worldwide. The one ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
(Date:1/19/2017)... ... 2017 , ... Ultimate Medical Academy (UMA) is preparing to ... making a difference in the lives of the next generation of healthcare professionals. ... educational institution, has more than 30,000 alumni and employs more than 2,000 professionals. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Tribble Insurance Agency, a family owned and ... is inaugurating a charity event to honor Chad Phillip Dermyer, a local police trooper ... Chad Phillip Dermyer and his fellow officers were conducting routine stops of suspects when ...
(Date:1/19/2017)... San Mateo, CA (PRWEB) , ... January 19, ... ... now being taken in the 2017 Spring Create Real Impact contest from Impact ... through March 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 ...
Breaking Medicine News(10 mins):